Navigation Links
PRA Holdings Announces Proposed Private Offering of $375 Million Senior Notes Due 2023
Date:9/11/2013

RALEIGH, N.C., Sept. 11, 2013 /PRNewswire/ -- PRA Holdings, Inc. ("PRA"), a leading global contract research organization providing outsourced clinical development services to the biotechnology and pharmaceutical industries, announced today that Pinnacle Merger Sub, Inc., which will be merged with and into PRA Holdings, Inc. upon consummation of the offering, intends, subject to market and other conditions, to offer $375,000,000 aggregate principal amount of its Senior Notes due 2023 (the "Notes") in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). The Notes will be guaranteed on a senior basis by all of PRA's existing and future direct and indirect domestic subsidiaries that guarantee obligations under its senior secured credit facilities. This offering is expected to be made in connection with the proposed acquisition of PRA and RPS Parent Holding Corp. ("RPS"), a leading global contract research organization providing clinical development services to the biotechnology and pharmaceutical industry, by entities affiliated with Kohlberg Kravis Roberts & Co. L.P. (the "Sponsor"). The net proceeds from this offering will be used to finance in part the acquisition of PRA and RPS by the Sponsor, the repayment of existing debt of PRA and RPS and the payment of fees and expenses in connection with such transactions.

The Notes and the related guarantees will be offered only to qualified institutional buyers in reliance on the exemption from registration set forth in Rule 144A under the Securities Act, and outside the United States to non-U.S. persons in reliance on the exemption from registration set forth in Regulation S under the Securities Act. The Notes and the related guarantees have not been registered under the Securities Act, or the securities laws of any state or other jurisdiction, and may not be offered or sold in the United States without registration or an applicable exemption from the Securities Act and applicable state securities or blue sky laws and foreign securities laws.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, any securities, nor shall there be any sales of the Notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.


'/>"/>
SOURCE PRA Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results
2. InfuSystem Holdings, Inc. To Announce First Quarter 2012 Financial Results On May 21, 2012
3. InfuSystem Holdings, Inc. Receives Letter From NYSE MKT Regarding Timely Notice Of Record Date For 2012 Annual Meeting Of Stockholders
4. InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012
5. Accident Fund Holdings Aims to Improve Control of Drug Utilization and Quality of Care with Change in Pharmacy Benefit Manager
6. China Kanghui Holdings Reports First Quarter 2012 Financial Results
7. InfuSystem Holdings Modifies Bylaws to Align with Corporate Governance Best Practices
8. InfuSystem Holdings, Inc. Terminates "Poison Pill" Plan
9. Golden Meditech Holdings Limited Announces 2011/ 2012 Annual Results
10. Hill-Rom Holdings, Inc. Hosts Fiscal 2012 Third Quarter Earnings Conference Call and Webcast
11. RoundTable Healthcare Partners Portfolio Company, Renaissance Acquisition Holdings, LLC Acquires DPT Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Research and Markets has announced the addition of ... to their offering. ... latest research Hemophilia Drugs Price Analysis and Strategies - 2016, provides drug ... answers the following questions: What are the ... positioned in the Global Hemophilia market? What are the ...
(Date:2/24/2017)... Physician General Dr. Rachel Levine ... Jennifer Smith commended South Central EMS today for ... naloxone, a life-saving overdose reversal drug. The recognition event ... and overdose survivor who was saved due to the ... significant part of fighting the opioid epidemic is making ...
(Date:2/24/2017)... 2017 Medical information groups within the ... self-service capabilities to manage inquiries from external stakeholders ... New research from consulting leader Best Practices, LLC ... website portals where HCPs can sign on and ... many findings to emerge from the new study ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... The Radiology Business Management ... radiology marketing programs at the annual Building Better Radiology Marketing Programs conference, ... Hotel in Fort Worth, Texas. Nine awards are given out in five categories. They ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... an official 2017 partnership with The Jensie Gran Fondo of Marin. For the ... UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease ... will be participating in Rare Disease Day events, hosted by the Rare Disease ... Disease Report, a website, weekly e-newsletter and quarterly publication, will be conducting interviews ...
(Date:2/23/2017)... ... 23, 2017 , ... Rosica Communications, a national PR ... media management, corporate communications, SEO and cause marketing, is opening an office in ... Hampshire, Massachusetts and Canada, Rosica will focus on expanding its footprint. , ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink ... publication where generations converge and explore the world from different perspectives. By providing ... enables readers to gain understanding, increase empathy, and find greater happiness. , ...
Breaking Medicine News(10 mins):